Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: A Study of JS207 (PD-1/VEGF Bispecific Antibody) in Combination With Chemotherapy in Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 study of JS207, a PD-1/VEGF bispecific antibody, in combination with chemotherapy for advanced non-squamous non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating APL-101 in non-small cell lung cancer with MET exon 14 skipping mutations and MET dysregulation, as well as other M…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: A Multicenter Phase II Randomized Trial of Limertinib Followed by Sintilimab and Chemotherapy vs. Limertinib Followed by Limertinib and Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB EGFR-Mutant NSCLC [Phase 2]
This is a Phase II randomized neoadjuvant trial in resectable EGFR-mutant non-small cell lung cancer comparing limertinib followed by sintil…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Neoadjuvant and Adjuvant Therapy Studies of Sindilizumab in Resectable Lung Cancer [Phase 3]
Phase 3 trials are evaluating sintilimab as neoadjuvant and adjuvant therapy for resectable non-small cell lung cancer. The study status is …
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Outpatient Pulmonary Rehabilitation in Non-small-cell Lung Cancer Receiving Immunotherapy [NA]
An outpatient pulmonary rehabilitation study in patients with non-small-cell lung cancer receiving immunotherapy is currently recruiting. Th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Early Palliative Care in Patients With Advanced Lung Cancer Using an e-Health Ecosystem [NA]
The trial is investigating early palliative care for patients with advanced non-small cell lung cancer using an electronic health ecosystem.…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive) [Phase 2]
A Phase 2 clinical trial evaluating whether osimertinib can suppress progression of ground-glass nodules in EGFR mutation-positive lung canc…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study [Phase 3]
Phase 3 non-inferiority trial evaluating maintenance pembrolizumab at standard versus low dose in metastatic non-small cell lung cancer; cur…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors [Phase 1]
A Phase 1 trial update for KJ015 in HER2-expressing solid tumors shows the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC [Phase 2]
A Phase 2 clinical trial evaluating neoadjuvant adebrelimab plus chemotherapy for resectable non-small cell lung cancer, with recruitment no…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer
A pilot clinical study is evaluating whether fractional exhaled nitric oxide can serve as a prognostic biomarker for response to anti-PD-L1 …
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Pembrolizumab for Advanced NSCLC and PS 2-3 [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab for advanced non-small cell lung cancer with performance status 2-3 is currently recruitin…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
This clinical trial update describes a study evaluating the efficacy and safety of chemoimmunotherapy combined with carbon ion radiotherapy …
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Enteral Nutrition With L-Carnitine for Cachexia in Non-Small Cell Lung Cancer [NA]
This clinical trial investigates enteral nutrition supplemented with L-Carnitine to address cachexia in patients with non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer [Phase 2, Phase 3]
This clinical trial entry describes an ongoing Phase 2/Phase 3 study evaluating electroacupuncture plus immune checkpoint inhibitors as adju…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer [Phase 3]
Phase 3 clinical trial evaluating ociperlimab with tislelizumab versus pembrolizumab in untreated non-small cell lung cancer; the study is a…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: SSGJ-707 in Advanced Non-Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial update for the investigational drug SSGJ-707 in advanced non-small cell lung cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: A Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status [Phase 2]
A Phase 2 clinical trial is evaluating a PD-1 inhibitor in combination with denosumab and chemotherapy for locally advanced or metastatic no…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT) [Phase 3]
Phase 3 trial update to compare furmonertinib against platinum-based chemotherapy in locally advanced or metastatic non-small cell lung canc…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial update evaluating the combination of Patritumab Deruxtecan (HER3-DXd) with Osimertinib in patients with locally adv…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This trial update describes a dose-escalation and dose-expansion study of MDX2001 in patients with advanced solid tumors, currently recruiti…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer [Phase 2]
A Phase 2, single-arm multicenter trial evaluating neoadjuvant therapy with Adebrelimab plus Apatinib for resectable non-small cell lung can…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors [Phase 2]
A Phase 2 clinical trial by Iovance Biotherapeutics evaluating autologous tumor-infiltrating lymphocytes in solid tumors is currently recrui…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Radical Resection With Contralateral Lymph Node Dissection for Clinical N3 NSCLC [NA]
A surgical trial evaluating radical resection with contralateral lymph node dissection for clinical N3 non-small cell lung cancer is current…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29) [Phase 2]
Phase 2 trial evaluating DZD9008 in combination with Bevacizumab for locally advanced or metastatic non-small cell lung cancer with EGFR mut…